Skip to content

Ocular Therapeutix OCUL Change in Lease Liabilities

Change in Lease Liabilities at other companies

Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-$3.19M-17.8%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-$608K-392%
TG Therapeutics logo
TG TherapeuticsTGTX
-$424K+21.9%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
-$375K-16.8%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$349K-13.7%
PVL
Palvella TherapeuticsPVLA
-$49K

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's change in lease liabilities?
Ocular Therapeutix (OCUL) reported change in lease liabilities of $1.77M in Q1 2026.
How has Ocular Therapeutix's change in lease liabilities changed year-over-year?
Ocular Therapeutix's change in lease liabilities increased by 790.6% year-over-year, from -$256K to $1.77M.
What is the long-term trend for Ocular Therapeutix's change in lease liabilities?
Over 4 years (2021 to 2025), Ocular Therapeutix's change in lease liabilities has grown at a 5.1% compound annual growth rate (CAGR), from -$1.36M to -$1.66M.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.